• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用综合生物信息学分析和验证研究鉴定宫颈癌中作为潜在预后生物标志物的关键基因

Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.

作者信息

Xue Han, Sun Zhaojun, Wu Weiqing, Du Dong, Liao Shuping

机构信息

Department of Health Management, Shenzhen People's Hospital, Shenzhen City, Guangdong Province, People's Republic of China.

Department of Dermatology, Shenzhen People's Hospital, Shenzhen City, GuangdongProvince, People's Republic of China.

出版信息

Cancer Manag Res. 2021 Jan 8;13:117-131. doi: 10.2147/CMAR.S282989. eCollection 2021.

DOI:10.2147/CMAR.S282989
PMID:33447084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7802793/
Abstract

BACKGROUND

Cervical cancer belongs to one of the most common female cancers; yet, the exact underlying mechanisms are still elusive. Recently, microarray and sequencing technologies have been widely used for screening biomarkers and molecular mechanism discovery in cancer studies. In this study, we aimed to analyse the microarray datasets using comprehensive bioinformatics tools and identified novel biomarkers associated with the prognosis of patients with cervical cancer.

METHODS

The differentially expressed genes (DEGs) from Gene Expression Omnibus (GEO) datasets including GSE138080, GSE113942 and GSE63514 were analysed using GEO2R tool. The functional enrichment analysis was performed using g:Profiler tool. The protein-protein interaction (PPI) network construction and hub genes identification were performed using the STRING database and Cytoscape software, respectively. The hub genes were subjected to expression and survival analysis in the cervical cancer. The EdU incorporation and Cell Counting Kit-8 assays were performed to evaluate the effects of hub gene knockdown on the proliferation of cervical cancer cells.

RESULTS

A total of 89 overlapping DEGs (63 up-regulated and 26 down-regulated genes) were identified in the microarray datasets. The functional enrichment analysis indicated that the overlapping DEGs were mainly associated with "DNA replication" and "cell cycle". Furthermore, the PPI network analysis revealed that the network contains 87 nodes and 309 edges. Sub-module analysis using the Molecular Complex Detection tool identified 21 hub genes from the PPI network. The expression levels of the 21 hub genes were all up-regulated in the cervical cancer tissues when compared to normal cervical tissues as analysed by GEPIA tool. The survival analysis showed that the low expression of cell division cycle 45 (), GINS complex subunit 2 (), minichromosome maintenance complex component 2 () and proliferating cell nuclear antigen () was significantly correlated with the shorter overall survival of patients with cervical cancer. Moreover, the protein expression levels of and , but not were significantly up-regulated in the cervical cancer tissues when compared to normal cervical tissues. Finally, knockdown of significantly suppressed the proliferation of HeLa and SiHa cells.

CONCLUSION

In conclusion, we screened a total of 89 overlapping DEGs from the GEO datasets, and further analysis identified four hub genes ( and ) that were likely associated with the prognosis of patients with cervical cancer. knockdown repressed the cervical cancer cell proliferation. The current findings may provide novel insights into understanding the pathophysiology of cervical cancer and develop therapeutic targets for patients with cervical cancer.

摘要

背景

宫颈癌是最常见的女性癌症之一;然而,其确切的潜在机制仍不清楚。最近,微阵列和测序技术已广泛用于癌症研究中的生物标志物筛选和分子机制发现。在本研究中,我们旨在使用综合生物信息学工具分析微阵列数据集,并鉴定与宫颈癌患者预后相关的新生物标志物。

方法

使用GEO2R工具分析来自基因表达综合数据库(GEO)数据集(包括GSE138080、GSE113942和GSE63514)的差异表达基因(DEG)。使用g:Profiler工具进行功能富集分析。分别使用STRING数据库和Cytoscape软件构建蛋白质-蛋白质相互作用(PPI)网络并鉴定枢纽基因。对枢纽基因进行宫颈癌中的表达和生存分析。进行EdU掺入和细胞计数试剂盒-8测定以评估枢纽基因敲低对宫颈癌细胞增殖的影响。

结果

在微阵列数据集中共鉴定出89个重叠的DEG(63个上调基因和26个下调基因)。功能富集分析表明,重叠的DEG主要与“DNA复制”和“细胞周期”相关。此外,PPI网络分析显示该网络包含87个节点和309条边。使用分子复合物检测工具进行的子模块分析从PPI网络中鉴定出21个枢纽基因。如通过GEPIA工具分析,与正常宫颈组织相比,这21个枢纽基因在宫颈癌组织中的表达水平均上调。生存分析表明,细胞分裂周期45()、GINS复合物亚基2()、微小染色体维持复合物组分2()和增殖细胞核抗原()的低表达与宫颈癌患者较短的总生存期显著相关。此外,与正常宫颈组织相比,表示为 和 的蛋白质表达水平在宫颈癌组织中显著上调,但表示为 的蛋白质表达水平未显著上调。最后,敲低 显著抑制了HeLa和SiHa细胞的增殖。

结论

总之,我们从GEO数据集中筛选出总共89个重叠的DEG,进一步分析鉴定出四个可能与宫颈癌患者预后相关的枢纽基因( 和 )。敲低 和 可抑制宫颈癌细胞增殖。目前的研究结果可能为理解宫颈癌的病理生理学提供新的见解,并为宫颈癌患者开发治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/c25911c5f075/CMAR-13-117-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/b888a1654abf/CMAR-13-117-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/b1fa7d9c54cf/CMAR-13-117-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/5512abca965a/CMAR-13-117-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/814504fdcae9/CMAR-13-117-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/634c8fe2d656/CMAR-13-117-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/6bb14d4c2d9e/CMAR-13-117-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/828d4c4eb419/CMAR-13-117-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/ed309c9f50ed/CMAR-13-117-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/81302f49fcdd/CMAR-13-117-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/f266fa42b215/CMAR-13-117-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/c25911c5f075/CMAR-13-117-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/b888a1654abf/CMAR-13-117-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/b1fa7d9c54cf/CMAR-13-117-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/5512abca965a/CMAR-13-117-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/814504fdcae9/CMAR-13-117-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/634c8fe2d656/CMAR-13-117-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/6bb14d4c2d9e/CMAR-13-117-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/828d4c4eb419/CMAR-13-117-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/ed309c9f50ed/CMAR-13-117-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/81302f49fcdd/CMAR-13-117-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/f266fa42b215/CMAR-13-117-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74b5/7802793/c25911c5f075/CMAR-13-117-g0011.jpg

相似文献

1
Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.利用综合生物信息学分析和验证研究鉴定宫颈癌中作为潜在预后生物标志物的关键基因
Cancer Manag Res. 2021 Jan 8;13:117-131. doi: 10.2147/CMAR.S282989. eCollection 2021.
2
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.通过生物信息学分析鉴定与 SCLC 相关的候选生物标志物和途径。
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
3
Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.使用综合生物信息学分析研究宫颈癌中差异表达的微小RNA和基因。
Oncol Lett. 2017 Apr;13(4):2784-2790. doi: 10.3892/ol.2017.5766. Epub 2017 Feb 22.
4
Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.宫颈癌新型潜在生物标志物和小分子药物的筛选与发现:生物信息学分析。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820980112. doi: 10.1177/1533033820980112.
5
Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.通过综合多组学方法解读宫颈癌相关生物标志物
Am J Transl Res. 2022 Dec 15;14(12):8843-8861. eCollection 2022.
6
GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.GOLM1 预测 NSCLC 患者的预后不良,并与 NSCLC 细胞中顺铂的增殖和化疗敏感性相关:生物信息学分析和实验室验证。
J Bioenerg Biomembr. 2021 Apr;53(2):177-189. doi: 10.1007/s10863-021-09875-7. Epub 2021 Feb 4.
7
Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.通过综合生物信息学分析鉴定预测结直肠癌预后的关键基因
Oncol Lett. 2020 Jan;19(1):388-398. doi: 10.3892/ol.2019.11068. Epub 2019 Nov 7.
8
Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation.通过综合生物信息学分析和实验验证鉴定与卵巢癌患者预后相关的枢纽基因
Cancer Manag Res. 2021 Jan 26;13:707-721. doi: 10.2147/CMAR.S282529. eCollection 2021.
9
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
10
Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis.利用生物信息学和实验分析鉴定骨肉瘤中潜在的关键基因及CENPF的功能作用。
Exp Ther Med. 2022 Jan;23(1):80. doi: 10.3892/etm.2021.11003. Epub 2021 Nov 25.

引用本文的文献

1
Novel bioinformatic approaches show the role of driver genes in the progression of cervical cancer: An in-silico study.新型生物信息学方法揭示驱动基因在宫颈癌进展中的作用:一项计算机模拟研究。
Heliyon. 2024 Nov 14;10(22):e40179. doi: 10.1016/j.heliyon.2024.e40179. eCollection 2024 Nov 30.
2
Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study.通过蛋白质-蛋白质相互作用分析鉴定与宫颈癌相关的可药物化枢纽基因和关键通路:一项计算机模拟研究
Int J Reprod Biomed. 2023 Nov 24;21(10):809-818. doi: 10.18502/ijrm.v21i10.14536. eCollection 2023 Oct.
3

本文引用的文献

1
The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.治疗和影像学手段在全球宫颈癌管理中的作用和贡献:基于模拟分析的生存估计。
Lancet Oncol. 2020 Aug;21(8):1089-1098. doi: 10.1016/S1470-2045(20)30316-8.
2
GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling.GINS2 通过特异性地刺激 ERK/MAPK 信号通路促进胰腺癌中的 EMT。
Cancer Gene Ther. 2021 Aug;28(7-8):839-849. doi: 10.1038/s41417-020-0206-7. Epub 2020 Aug 3.
3
Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
Systematic approach to identify therapeutic targets and functional pathways for the cervical cancer.
识别宫颈癌治疗靶点和功能通路的系统方法。
J Genet Eng Biotechnol. 2023 Feb 1;21(1):10. doi: 10.1186/s43141-023-00469-x.
4
Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.通过综合多组学方法解读宫颈癌相关生物标志物
Am J Transl Res. 2022 Dec 15;14(12):8843-8861. eCollection 2022.
5
MCM2 in human cancer: functions, mechanisms, and clinical significance.人癌症中的MCM2:功能、机制及临床意义
Mol Med. 2022 Oct 27;28(1):128. doi: 10.1186/s10020-022-00555-9.
6
Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.进行元数据分析以探索枢纽基因的核心,突出其在宫颈癌诊断和治疗中的功能、通路及调控因子。
Discov Oncol. 2022 Aug 22;13(1):79. doi: 10.1007/s12672-022-00546-6.
7
Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.通过生物信息学方法鉴定宫颈癌中的新基因及相关药物
Med Sci Monit. 2022 Apr 16;28:e934799. doi: 10.12659/MSM.934799.
8
Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.基于 mRNA 表达谱的生物信息学筛选宫颈癌潜在生物标志物以发现药物靶点和药物。
Int J Mol Sci. 2022 Apr 2;23(7):3968. doi: 10.3390/ijms23073968.
9
Research Progress of PCNA in Reproductive System Diseases.增殖细胞核抗原在生殖系统疾病中的研究进展
Evid Based Complement Alternat Med. 2021 Oct 21;2021:2391917. doi: 10.1155/2021/2391917. eCollection 2021.
基于转录组测序分析的 BRCA1 对宫颈鳞癌同步放化疗耐药的影响。
Biomed Res Int. 2020 Jun 21;2020:3598417. doi: 10.1155/2020/3598417. eCollection 2020.
4
Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.通过综合生物信息学分析筛选和鉴定炎症性乳腺癌的关键生物标志物。
Genet Test Mol Biomarkers. 2020 Aug;24(8):484-491. doi: 10.1089/gtmb.2020.0047. Epub 2020 Jun 27.
5
RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.RYBP 通过下调 G1-S 期转换过程中的 CDC6 和 CDC45 抑制食管鳞癌细胞增殖。
Life Sci. 2020 Jun 1;250:117578. doi: 10.1016/j.lfs.2020.117578. Epub 2020 Mar 21.
6
Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.更新的人口统计学、残疾权重和宫颈癌负担对全球、区域和国家各级人乳头瘤病毒疫苗接种效果估计的影响:PRIME 模型研究。
Lancet Glob Health. 2020 Apr;8(4):e536-e544. doi: 10.1016/S2214-109X(20)30022-X. Epub 2020 Feb 24.
7
Potential Prognostic and Diagnostic Values of CDC6, CDC45, ORC6 and SNHG7 in Colorectal Cancer.CDC6、CDC45、ORC6和SNHG7在结直肠癌中的潜在预后和诊断价值
Onco Targets Ther. 2019 Dec 31;12:11609-11621. doi: 10.2147/OTT.S231941. eCollection 2019.
8
Eliminating cervical cancer.消除宫颈癌。
Lancet. 2020 Feb 1;395(10221):312. doi: 10.1016/S0140-6736(20)30247-6.
9
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.实现世界卫生组织宫颈癌消除目标的死亡率影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):591-603. doi: 10.1016/S0140-6736(20)30157-4. Epub 2020 Jan 30.
10
Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.微小染色体维持复合体(MCM)基因谱分析及MCM2蛋白表达在宫颈癌发生发展中的作用
Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3043-3049. doi: 10.31557/APJCP.2019.20.10.3043.